Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk would violate U.S. antitrust law. Metsera called the arguments “nonsense” ...

With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs.

The government shutdown is still underway, and a key sticking point of this shutdown is the expiration of the Affordable Care Act’s enhanced premium tax credits at the end of the year. These were ...

From left to right: Moderator Dennis Dailey, editor at mHealth Times; Dave Chokshi, primary care doctor at Bellevue Hospital and chair of the Common Health Coalition; Pete November, CEO of Ochsner ...

At the HLTH 2025 conference, healthcare executives shared how their companies perceive the shifting healthcare landscape and how their health tech companies fit into it. Wolters Kluwer Health Director ...